Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 01-2022 | 10-2021 | 07-2021 | 04-2021 | 01-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,982 | 55,490 | 57,269 | 19,584 | 6 |
| Receivables | 27 | 19 | 13 | 15 | 5 |
| TOTAL | $48,316 | $55,916 | $57,798 | $20,288 | $213 |
| Non-Current Assets | |||||
| Intangibles | 238 | 242 | 246 | 243 | 242 |
| TOTAL | $238 | $242 | $246 | $243 | $242 |
| Total Assets | $48,554 | $56,158 | $58,044 | $20,531 | $454 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 125 |
| Accounts payable and accrued liabilities | 605 | 431 | 214 | 166 | 3,529 |
| Accrued Expenses | N/A | N/A | 343 | N/A | N/A |
| TOTAL | $605 | $431 | $557 | $166 | $3,913 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 249 | 333 | 29,815 | 6,886 | 149 |
| TOTAL | $249 | $333 | $29,815 | $6,886 | $149 |
| Total Liabilities | $854 | $765 | $30,372 | $7,052 | $4,061 |
| Shareholders' Equity | |||||
| Common Shares | 53,937 | 55,358 | 54,774 | 24,669 | 12,050 |
| Retained earnings | -22,759 | -18,140 | -29,142 | -13,663 | -17,985 |
| Other shareholders' equity | 16,522 | 18,175 | -139 | 2,473 | 2,329 |
| TOTAL | $47,700 | $55,393 | $27,672 | $13,479 | $-3,607 |
| Total Liabilities And Equity | $48,554 | $56,158 | $58,044 | $20,531 | $454 |